Raul Nogueira, MD
Vascular Neurology · Pittsburgh, PANPI 1912975921
Payments from drug & device makers
What this record shows
The money is spread across several categories — ownership interests (51.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Corindus Inc. at 51.5% of the total. Reporting peaked in 2019 at $603,214 and has fallen 91.6% since, to $50,666 in 2025. Among vascular neurology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $3610.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corindus Inc.$478K
- Stryker$211K
- Medical Device Business Services, Inc.$127K
- Neurovasc Technologies, Inc.$32K
- Medtronic$20K
- Phenox Inc.$17K
- plus $45K from 14 others
Across 35 payments — averaging $160,643 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$4.9M
- Stryker$678K
- Genentech, Inc.$46K
- Biogen$4K
Across 7 payments — averaging $33,993 each. An ownership or investment interest held by the physician or an immediate family member.
- Tulavi Therapeutics, Inc.$131K
- Perfuze Limited$107K
- Viz.ai, Inc.$0
- Imperative Care, Inc$0
What the payments were for
- Consulting fees$338,06736%
- Speaking & faculty fees$21,5502%
- Travel & lodging$85,0259%
- Food & beverage$6,3181%
- Ownership interest$477,00051%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corindus Inc. | 5 | $477,799 |
| Stryker | 99 | $210,793 |
| Medical Device Business Services, Inc. | 82 | $126,576 |
| Neurovasc Technologies, Inc. | 3 | $31,664 |
| Medtronic(2 entities) | 18 | $20,043 |
| Phenox Inc. | 3 | $16,502 |
| Route 92 Medical, Inc. | 6 | $12,544 |
| Perfuze Limited | 2 | $8,401 |
| Imperative Care, Inc | 4 | $6,252 |
| Biogen | 12 | $4,420 |
| Genentech USA, Inc. | 1 | $3,750 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,150 |
| Depuy Synthes Products, Inc. | 1 | $2,475 |
| Microvention, Inc. | 4 | $2,394 |
| Balt USA, LLC | 3 | $417 |
| Johnson & Johnson | 5 | $248 |
| Viz.ai, Inc. | 1 | $242 |
| Biosense Webster, Inc. | 2 | $142 |
| Genentech, Inc. | 1 | $77 |
| Penumbra, Inc. | 4 | $72 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TREVO$141,913
- ATLAS$40,840
- TARGET$37,251
- EMBOGUARD$34,291
- NEUROFORM EZ$29,250
- EMBOTRAP II Revascularization Device$24,606
- Embotrap$21,825
- FLOWGATE2$18,438
- AXS CATALYST 7$18,438
- Pipeline$17,098
- pRESET$16,200
- Cerenovus Enterprise$15,750
- NEURO$14,148
- NEUROFORM EZ 3$13,990
- SURPASS EVOLVE$13,500
- AXS VECTA 71$13,450
- FLOWGATE$11,363
- CATALYST$11,363
- AXS INFINITY LS$10,125
- NEUROFORM ATLAS$10,125
How this compares
$927,961 in reported general payments places this provider in the 95th percentile of 52 vascular neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in Pittsburgh
- Jussie Correia LimaPittsburgh$85K
- Alhamza Al-BayatiPittsburgh$66K
- Neil SuryadevaraPittsburgh$9K
- Cynthia KenmuirPittsburgh$2K
- Liqi ShuPittsburgh$623
- Maryam ZulfiqarPittsburgh$526
- Murat SariPittsburgh$424
- Aaron Ravelo JimenezPittsburgh$418
- Elissa OrtolaniPittsburgh$349
- Matthew StarrPittsburgh$321
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.